south korea
South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines
February 16, 2021Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea
South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.
South Korea secures enough COVID-19 vaccine doses for 44 million citizens
December 8, 2020Manufacturing and Production, Sales and Marketing COVID-19, Vaccine, south korea
The South Korean Government has announced plans to secure enough COVID-19 vaccine doses to inoculate 44 million of its citizens, …
India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19
June 3, 2020Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea
India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …
South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients
May 6, 2020Research and Development COVID-19, coronavirus, south korea
South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. South …
South Korea jails executives for their role in Samsung Biologics fraud
December 10, 2019Manufacturing and Production Samsung phones, Sanofi, Sanofi Diabetes, South Korea Healthcare System, South Korea Samsung, diabetes, inhaled insulin, insulin, south korea
Three executives of Samsung Electronics have been sentenced to jail for their role in committing fraud at its biotech affiliate …
Singapore and South Korea agree to cooperate on Good Manufacturing Practice
November 26, 2019Manufacturing and Production ASEAN, GMP, North Korea, ROK, Singapore, south korea
At a joint summit on Saturday, South Korea’s Ministry of Food and Drug Safety signed a memorandum of understanding (MOU) …
Samsung BioLogics delisted over accounting violations
November 14, 2018Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea
South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …
J&J buy global rights to Yuhan’s lazertinib in deal worth $1.2bn
November 6, 2018Manufacturing and Production J&J, JJ, NSCLC, Yuhan, deal, lazertinib, south korea
Johnson & Johnson’s Janssen Biotech unit has bought the rights to Yuhan’s third-generation EGFR tyrosine kinase inhibitor (TKI) lazertinib in a deal …
Samsung BioLogics’ shares down $6bn after accounting furore
May 2, 2018Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea
Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …
J&J offers $134,000 grant to find the best start-up in South Korea
August 31, 2017Research and Development J&J. pharma, Johnson & Johnson, drugs, life sciences, medicine, pharmaceutical, south korea
Johnson & Johnson is doubling down its efforts to grow its business in East Asia by identifying and recruiting promising …
South Korea fines Novartis over kickbacks scandal
March 2, 2017Medical Communications, Sales and Marketing Kickback, Novartis, south korea
South Korea’s Ministry of Food and Drug Safety has fined Novartis 200 million won ($174,936) over the payment of kickbacks …
South Korea’s workforce expands 27% in last four years
November 7, 2016Manufacturing and Production, Sales and Marketing Employment, manufacturing, production, south korea
South Korea’s pharmaceutical workforce has expanded by 27% in the last four years. The growth in jobs is can be …
Hanmi Pharmaceutical raided over insider trading suspicions
October 17, 2016Sales and Marketing Boehringer Ingelheim, Genentech, Hanmi Pharmaceutical, south korea
At the end of September, we reported on a busy 24-hour for Hanmi Pharmaceutical, as they secured a deal with …
Hanmi Pharma shares crash after shock contract termination
September 30, 2016Manufacturing and Production, Medical Communications, Research and Development Boehringer Ingelheim, Genentech, Germany, HM61713, Hanmi Pharmaceutical, Tagrisso, south korea
News broke on 29 September that Hanmi Pharma, South Korea’s leading drug maker, had signed a $910 million deal with …
Novartis admits employees gave kickbacks to doctors in South Korea
August 12, 2016Medical Communications, Research and Development Novartis, kickbacks, south korea
Novartis has confirmed that six employees in South Korea gave kickbacks to doctors, as the current and former employees face …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
